Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 15790766)

1.

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.

am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, Burchardt ER, Feifel N, Stoldt V, Stockschläder M, Stoecklein N, Tustas RY, Eisenberger CF, Peiper M, Häussinger D, Hosch SB.

Stem Cells. 2005 Apr;23(4):463-70.

2.

[Stem cell-induced liver regeneration].

Knoefel WT, Alexander A, Tustas RY, Schmelzle M, Klein HM, Krieg A, Topp SA, Eisenberger CF, Fuerst G, Schulte am Esch J 2nd.

Zentralbl Chir. 2013 Apr;138(2):166-72. doi: 10.1055/s-0031-1271587. Epub 2011 Nov 15. German.

PMID:
22086774
3.

Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.

Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, Godehardt E, Krieg A, Wecker B, Stoldt V, Stockschläder M, Eisenberger CF, Mödder U, Knoefel WT.

Radiology. 2007 Apr;243(1):171-9. Epub 2007 Feb 20.

PMID:
17312278
4.

Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.

am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, Tustas RY, Alexander A, Klein HM, Topp SA, Bode JG, Häussinger D, Eisenberger CF, Knoefel WT.

Ann Surg. 2012 Jan;255(1):79-85. doi: 10.1097/SLA.0b013e31823d7d08.

PMID:
22156926
5.

Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.

Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, Lee SK, Hong HN.

Ann Surg. 2009 Apr;249(4):608-16. doi: 10.1097/SLA.0b013e31819ecc5c.

PMID:
19300228
7.

Autologous CD133+ cells augment the effect of portal embolization.

Canepa MC, Quaretti P, Perotti C, Vercelli A, Rademacher J, Peloso A, Barbieri L, Franchi E, Briani L, Gaspari A, Brugnatelli S, Pedrazzoli P, Dionigi P, Maestri M.

Minerva Chir. 2013 Apr;68(2):163-8.

PMID:
23612229
8.
9.

Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection.

van den Esschert JW, de Graaf W, van Lienden KP, Busch OR, Heger M, van Delden OM, Gouma DJ, Bennink RJ, Laméris JS, van Gulik TM.

J Gastrointest Surg. 2009 Aug;13(8):1464-9. doi: 10.1007/s11605-009-0929-0. Epub 2009 May 28.

10.

Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.

Ahmadi H, Baharvand H, Ashtiani SK, Soleimani M, Sadeghian H, Ardekani JM, Mehrjerdi NZ, Kouhkan A, Namiri M, Madani-Civi M, Fattahi F, Shahverdi A, Dizaji AV.

Curr Neurovasc Res. 2007 Aug;4(3):153-60.

PMID:
17691968
11.

Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats.

Li T, Zhu J, Ma K, Liu N, Feng K, Li X, Wang S, Bie P.

J Surg Res. 2013 Oct;184(2):1161-73. doi: 10.1016/j.jss.2013.04.054. Epub 2013 May 16.

PMID:
23809154
12.

Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?

Tashiro S.

J Hepatobiliary Pancreat Surg. 2009;16(3):292-9. doi: 10.1007/s00534-009-0058-x. Epub 2009 Mar 31. Review.

PMID:
19333540
13.

Two-stage hepatectomy after autologous CD133+ stem cells administration: a case report.

Franchi E, Canepa MC, Peloso A, Barbieri L, Briani L, Panyor G, Dionigi P, Maestri M.

World J Surg Oncol. 2013 Aug 13;11(1):192. doi: 10.1186/1477-7819-11-192.

14.

Pre-hepatectomy portal vein embolization: single center experience.

Cotroneo AR, Innocenti P, Marano G, Legnini M, Iezzi R.

Eur J Surg Oncol. 2009 Jan;35(1):71-8. doi: 10.1016/j.ejso.2008.07.006. Epub 2008 Aug 22.

PMID:
18722746
15.

Intra-portal transplantation of bone marrow stromal cells ameliorates liver fibrosis in mice.

Zheng JF, Liang LJ.

Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):264-70.

16.

HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection.

Lehwald N, Duhme C, Wildner M, Kuhn S, Fürst G, Forbes SJ, Jonas S, Robson SC, Knoefel WT, Schmelzle M, Schulte Am Esch J.

Liver Int. 2014 Jan;34(1):89-101. doi: 10.1111/liv.12195. Epub 2013 May 23.

PMID:
23701640
17.

Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.

Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D'Angelica M, Getrajdman GI, DeMatteo R, Kemeny NE, Fong Y.

Ann Surg. 2008 Mar;247(3):451-5. doi: 10.1097/SLA.0b013e31815ed693.

PMID:
18376189
18.

Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.

Nikeghbalian S, Pournasr B, Aghdami N, Rasekhi A, Geramizadeh B, Hosseini Asl SM, Ramzi M, Kakaei F, Namiri M, Malekzadeh R, Vosough Dizaj A, Malek-Hosseini SA, Baharvand H.

Arch Iran Med. 2011 Jan;14(1):12-7. doi: 011141/AIM.004.

19.

What is the role of bone marrow-derived stem cells in hepatic hypertrophy after portal vein embolization?

Zaydfudim VM, Smoot RL, Nagorney DM.

Ann Surg. 2015 Jan;261(1):e25-6. doi: 10.1097/SLA.0000000000000423. No abstract available.

PMID:
24368660
20.

Preoperative portal vein embolization for liver malignancies.

Tarazov PG, Granov DA, Sergeev VI, Polikarpov AA, Polysalov VN, Rozengauz EV.

Hepatogastroenterology. 2006 Jul-Aug;53(70):566-70.

PMID:
16995463
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk